Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

The Lead

The Story of Biogen's Alzheimer's Drug, Aducanumab

April 28, 2015 | by Cynthia Fox, Science Writer | Articles | Comments

The Biogen anti-amyloid antibody, aducanumab, took the 12th International Conference on Alzheimer’s and Parkinson’s Diseases in Nice, France by storm last month. The drug seemed able to significantly reduce amyloid in patients’ brains, while demonstrably slowing cognitive degeneration. It had analysts and scientists alike buzzing. Read more...

View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Scientists Uncover Surprising New Details of Potential Alzheimer’s Treatment

April 28, 2015 1:26 pm | by The Scripps Research Institute | News | Comments

Taking a new approach, scientists from the Florida campus of The Scripps Research Institute (TSRI) have uncovered some surprising details of a group of compounds that have shown significant potential in stimulating the growth of brain cells and memory restoration in animal models that mimic Alzheimer’s disease. Read more...


Two Treatments Yield Similar Results for Children After Cardiac Arrest

April 28, 2015 1:13 pm | by University of Michigan | News | Comments

A large-scale, multicenter study has shown that emergency body cooling does not improve survival rates or reduce brain injury in infants and children with out-of-hospital cardiac arrest more than normal temperature control. Read more...


Molecular Health Gains European Patent for Novel Receptor

April 28, 2015 8:54 am | News | Comments

It addresses unmet need in treatment of millions of cancer patients. Read more...


Microneedle Patch for Measles Vaccination Could be Global Game Changer

April 28, 2015 8:45 am | by Georgia Institute of Technology | News | Comments

A new microneedle patch could make it easier to vaccinate people against measles and other vaccine-preventable diseases. Read more...


GSK Shingles Vaccine Demonstrates 97.2% Efficacy in Phase 3 Study

April 28, 2015 8:37 am | News | Comments

GlaxoSmithKline presented detailed data from a randomized phase 3 study of its investigational vaccine candidate for the prevention of shingles. Read more...


An End to Cancer Pain?

April 28, 2015 8:25 am | by University of Toronto | News | Comments

A new study has discovered the trigger behind the most severe forms of cancer pain. Read more...


Ebola Scare May Inform U.S.'s Response to Bioterrorism

April 27, 2015 2:50 pm | by Seth Augenstein, Digital Reporter | Articles | Comments

Last year’s Ebola scare might provide a blueprint for a response to the unthinkable: a bioterrorist attack in the U.S. Read more...


Simultaneous Quantitation of Metabolic Hormones

April 27, 2015 1:22 pm | by Tina Rose, Research Scientist; Qiang Xiao, Ph.D., R&D Manager, EMD Millipore Corporation | Articles | Comments

This article describes a new assay panel that helps overcome these challenges. The MILLIPLEX® MAP Human Metabolic Hormone Magnetic Bead Panel (EMD Millipore) enables the simultaneous quantitation of metabolism-relevant analytes, Read more...


Scientists Use Gene Editing to Correct Mutation in Cystic Fibrosis

April 27, 2015 12:25 pm | News | Comments

Yale researchers successfully corrected the most common mutation in the gene that causes cystic fibrosis, a lethal genetic disorder. Read more..


TAXIS: Clinical Potential in Combating Antibiotic Resistance

April 27, 2015 12:19 pm | News | Comments

TAXIS Pharmaceuticals, a drug-discovery company focused on developing a new class of antibiotic agents to treat life-threatening, multidrug-resistant bacterial infections, today announced the presentation of data demonstrating the promise of its lead clinical candidate, TXA709, in combating antibiotic resistance. Read more...

Indiana HIV Outbreak, Hepatitis C Epidemic Sparks CDC Alert

April 27, 2015 12:14 pm | by Jeni O'Malley, Associated Press | News | Comments

An Indiana county is experiencing nearly daily increases in new HIV infections tied to intravenous drug use, and health officials hope the situation prompts other states to closely track their hepatitis C and HIV rates to identify potential clusters of the diseases. Read more..


Mylan Declines Teva's $40B Takeover Attempt

April 27, 2015 12:08 pm | by Ryan Bushey, Associate Editor | Articles | Comments

The executive chairman for Mylan wrote a letter to Teva citing a number of issues as to why this merger would be a bad idea. Read more...


Lilly's Cyramza Receives Fourth FDA Approval

April 27, 2015 12:07 pm | News | Comments

Eli Lilly and Company has received its fourth U.S. Food and Drug Administration (FDA) approval for Cyramza (ramucirumab). Read more...


Allergan to Cut Hundreds of U.S. Jobs

April 27, 2015 9:50 am | by Ryan Bushey, Associate Editor | Articles | Comments

A total of 674 staff members have been let go from Allergan’s operations in California so far since 2014. Read more...


Innovation Gives Pregnant Women with Diabetes Round-the-Clock Glucose Control

April 27, 2015 9:02 am | by University of Leeds | News | Comments

Achieving better glucose control in pregnant women with diabetes by using continuous glucose monitoring may help them give birth to healthier children. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.